Advertisement
Table 2 Objective responses and survival of the study population
| Variable | No. of Patients [cases (%)] | Median PFS | Median OS |
|---|---|---|---|
| (95% CI, months) | (95% CI, months) | ||
| Best response | |||
| Complete response | 0 | – | – |
| Partial response | 21 (32.3) | 7.80 (4.86–10.74) | 18.17 (12.89–23.45) |
| Stable disease | 27 (41.5) | 7.00 (4.43–9.57) | 13.00 (9.68–16.32) |
| Progressive disease | 16 (24.6) | 1.93 (1.59–2.28) | 4.30 (3.58–5.02) |
| Could not be evaluated | 1 (1.5) | – | – |
| Objective response ratea | 21 (32.3) | – | – |
| Disease control rateb | 48 (73.8) | – | – |
